Clover Health insider plans sale of 51,700 shares
Clover Health Investments (CLOV) insider Karen Soares filed to sell up to 51,700 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an aggregate market value of $238,854.00.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clover Health Investments (CLOV) insider Karen Soares filed to sell up to 51,700 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an aggregate market value of $238,854.00. The securities relate to Restricted Stock Units granted on 03/15/2026, with additional sales already made in the past three months.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Units financial
Rule 144 regulatory
aggregate market value financial
common stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing for CLOV by Karen Soares disclose?
What type of CLOV securities are covered by Karen Soares’ Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.